Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4831 AL 4845

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Kubo M, Kishi T, Matsunaga S, Iwata N.

J Alzheimers Dis. 2015;48(3):667-71. doi: 10.3233/JAD-150393.

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions

Bhat NR.

J Alzheimers Dis. 2015;46(3):581-91. doi: 10.3233/JAD-150098.

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.

J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.

Alzheimer's disease drug development based on Computer-Aided Drug Design

Zeng H, Wu X.

Eur J Med Chem. 2016 Oct 4;121:851-863. doi: 10.1016/j.ejmech.2015.08.039. Epub 2015 Sep 3.

Cerebral perfusional effects of 1-year rivastigmine treatment in Alzheimer disease: a case report

Ettorre E, Bersani FS, Colella F, Servello A, Minichino A, Megna V, Liberatore M, Biondi M, Marigliano V.

Riv Psichiatr. 2015 Jul-Aug;50(4):188-91. doi: 10.1708/2002.21650.

[Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease]

Kukharsky MS, Ovchinnikov RK, Bachurin SO.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):103-114. doi: 10.17116/jnevro20151156103-114.

Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical Trials

Zeng L, Zou Y, Kong L, Wang N, Wang Q, Wang L, Cao Y, Wang K, Chen Y, Mi S, Zhao W, Wu H, Cheng S, Xu W, Liang W.

Phytother Res. 2015 Dec;29(12):1843-57. doi: 10.1002/ptr.5481. Epub 2015 Oct 6.

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors

Kračmarová A, Drtinová L, Pohanka M.

Acta Medica (Hradec Kralove). 2015;58(2):37-42. doi: 10.14712/18059694.2015.91.

A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer's Disease

Keifer J, Zheng Z, Ambigapathy G.

Microrna. 2015;4(2):101-8. doi: 10.2174/2211536604666150813152620.

Nicotinic Cholinergic Mechanisms in Alzheimer's Disease

Shen J, Wu J.

Int Rev Neurobiol. 2015;124:275-92. doi: 10.1016/bs.irn.2015.08.002. Epub 2015 Sep 26.

Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective

Popugaeva E, Vlasova OL, Bezprozvanny I.

Neurodegener Dis Manag. 2015 Oct;5(5):395-8. doi: 10.2217/nmt.15.36. Epub 2015 Oct 19.

Developments and new vistas in the field of melanocortins

Leone S, Noera G, Bertolini A.

Biomol Concepts. 2015 Dec;6(5-6):361-82. doi: 10.1515/bmc-2015-0023.

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease

Sheng R, Tang L, Jiang L, Hong L, Shi Y, Zhou N, Hu Y.

ACS Chem Neurosci. 2016 Jan 20;7(1):69-81. doi: 10.1021/acschemneuro.5b00224. Epub 2015 Oct 28.

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease

Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL.

J Am Med Dir Assoc. 2016 Feb;17(2):142-7. doi: 10.1016/j.jamda.2015.08.019. Epub 2015 Oct 9.

The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review

Sheng C, Peng W, Xia ZA, Wang Y, Chen Z, Su N, Wang Z.

BMC Complement Altern Med. 2015 Oct 24;15:386. doi: 10.1186/s12906-015-0894-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias